{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:34:12Z","timestamp":1758710052631,"version":"3.44.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaad.2024.12.054","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T17:50:06Z","timestamp":1742925006000},"page":"e51-e52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on Vera et al\u2019s \u201cInterleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: A retrospective cohort study.\u201d"],"prefix":"10.1016","volume":"93","author":[{"given":"I-Chang","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2024.12.054_bib1","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.jaad.2025.03.058","article-title":"Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: a retrospective cohort study","volume":"93","author":"Vera","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2024.12.054_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.054_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjmed.2019.08.055","article-title":"Propensity score matching: the 'Devil is in the Details' where more may be hidden than you know","volume":"133","author":"Reiffel","year":"2020","journal-title":"Am J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T20:39:07Z","timestamp":1758659947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225005274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0190962225005274"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.054","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on Vera et al\u2019s \u201cInterleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: A retrospective cohort study.\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.058","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}